Inhibikase Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Inhibikase Therapeutics, Inc.‘s stocks are currently a part of 11 hedge funds’ portfolios, which represents 2.94% of the total amount of its stocks outstanding. This makes up a total of 741.45K shares of Inhibikase Therapeutics, Inc.. Compared to the previous quarter, the number fell by -48.53% or -699.21K shares fewer. As for the holding position changes, 36.36% (4) of current hedge fund investors increased the number of shares held, 18.18% (2) of current holders sold a part of the shares held, and 27.27% (3) closed the holdings completely. 2 hedge funds are new holders of Inhibikase Therapeutics, Inc. stock in Q1 2023, it is 18.18% of total holders.
Hedge funds holding Inhibikase Therapeutics (Q4 2020 – Q1 2023)
| Q4 2020 | 5 |
|---|---|
| Q1 2021 | 8 |
| Q2 2021 | 13 |
| Q3 2021 | 20 |
| Q4 2021 | 23 |
| Q1 2022 | 23 |
| Q2 2022 | 20 |
| Q3 2022 | 22 |
| Q4 2022 | 19 |
| Q1 2023 | 11 |
Hedge funds changes in Inhibikase Therapeutics positions (Q4 2020 – Q1 2023)
| Q4 2020 | 5 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2021 | 5 | 0 | 1 | 2 | 0 |
| Q2 2021 | 9 | 4 | 0 | 4 | -4 |
| Q3 2021 | 9 | 5 | 1 | 2 | 3 |
| Q4 2021 | 7 | 5 | 3 | 4 | 4 |
| Q1 2022 | 3 | 5 | 6 | 3 | 6 |
| Q2 2022 | 3 | 7 | 4 | 6 | 0 |
| Q3 2022 | 4 | 1 | 4 | 2 | 11 |
| Q4 2022 | 4 | 5 | 5 | 6 | -1 |
| Q1 2023 | 2 | 4 | 2 | 3 | 0 |